Aveanna Healthcare Holdings (AVAH) Gains from Sales and Divestitures: 2022-2024
Historic Gains from Sales and Divestitures for Aveanna Healthcare Holdings (AVAH) over the last 3 years, with Q4 2024 value amounting to $688865.0.
- Aveanna Healthcare Holdings' Gains from Sales and Divestitures rose 12361.75% to $688865.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $688865.0, marking a year-over-year increase of 12361.75%. This contributed to the annual value of $688865.0 for FY2024, which is 12361.75% up from last year.
- According to the latest figures from Q4 2024, Aveanna Healthcare Holdings' Gains from Sales and Divestitures is $688865.0, which was up 12361.75% from $308055.0 recorded in Q4 2023.
- Aveanna Healthcare Holdings' 5-year Gains from Sales and Divestitures high stood at $688865.0 for Q4 2024, and its period low was $308055.0 during Q4 2023.
- For the 3-year period, Aveanna Healthcare Holdings' Gains from Sales and Divestitures averaged around $439324.3, with its median value being $321053.0 (2022).
- As far as peak fluctuations go, Aveanna Healthcare Holdings' Gains from Sales and Divestitures tumbled by 404.86% in 2023, and later soared by 12361.75% in 2024.
- Aveanna Healthcare Holdings' Gains from Sales and Divestitures (Quarter) stood at $321053.0 in 2022, then fell by 4.05% to $308055.0 in 2023, then skyrocketed by 123.62% to $688865.0 in 2024.
- Its Gains from Sales and Divestitures stands at $688865.0 for Q4 2024, versus $308055.0 for Q4 2023 and $321053.0 for Q4 2022.